Health
Patients have little say in how brain implant trials are done. Ian Burkhart wants to change that
Publication: STAT
Author: O. Rose Broderick
Source published: 20/11/2026, 09:30:00 UTC
Briefing created: 21/11/2026, 02:03:21 UTC
Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 21/11/2026, 00:37:24 UTC.
Briefings
A new report examines how clinical trials for brain implantable interfaces can better protect participant interests, specifically addressing autonomy and data privacy. The article highlights a specific initiative by Ian Burkhart to change how trials are conducted, though the report itself does not provide specific numbers or dates for this initiative, only the general context of the field.
Key points
- Clinical trials for brain implantable interfaces often fail to allow participants to influence how the research is conducted.
- Participants may join trials as a last-ditch attempt to improve communication, mobility, or autonomy.
Context
The article explores how trials of implanted brain-computer interfaces can better address the interests and concerns of participants, who often join in a last-ditch attempt to improve their communication, mobility, or autonomy.
Limitations
The evidence is limited to the general context of the field and the specific initiative by Ian Burkhart, without specific numbers, dates, or outcomes for the initiative itself.
Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 21/11/2026, 02:03:21 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.
View archived briefing on IPFS
bafybeic4l2bzli7c6jkw5tlxpsoz3w5veraxcg6k6aaak6lflwkxlpee2q